.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
Argus Health
Chubb
US Department of Justice
Queensland Health
Chinese Patent Office

Generated: November 19, 2017

DrugPatentWatch Database Preview

Patent Applications for TAZTIA XT

« Back to Dashboard

US Patent Applications for TAZTIA XT

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
► Subscribe► SubscribePharmaceutical composition for angiotensin II-mediated diseases2001-01-12Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-03-17
► Subscribe► SubscribePOLYSACCHARIDE MICROSPHERES FOR THE PULMONARY DELIVERY OF DRUGS1998-10-30Abandoned -- Failure to Respond to an Office Action2002-09-19
► Subscribe► SubscribeDILTIAZEM CONTROLLED RELEASE FORMULATION AND METHOD OF MANUFACTURE1998-07-20Patented Case2003-02-06
► Subscribe► SubscribeDIAGNOSING AN ANIMAL FOR PYROPHOSPHATE GOUT, OSTEOPOROSIS , OR OSTEOARTHRITIS BY ASSAYING INTRACELLULAR PYROPHOSPHATE CONTENT IN PERIPHERAL BLOOD CELLS2001-01-04Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622011-03-21
► Subscribe► SubscribePHARMACEUTICAL COMPOSITION FOR ANGIOTENSIN II-MEDIATED DISEASES2001-02-15Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-08-11
► Subscribe► SubscribeINTRABUCCALLY RAPIDLY DISINTEGRATING TABLET1999-06-04Abandoned -- Failure to Respond to an Office Action2003-07-14
► Subscribe► SubscribeInjectable pharmaceutical composition for treatment and reversal of erectile dysfunction2001-03-02Abandoned -- Failure to Respond to an Office Action2003-05-19
► Subscribe► SubscribeUse of sulfamate derivatives for treating impulse control disorders2000-02-18Patented Case2001-11-09
► Subscribe► SubscribePharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity2001-01-31Abandoned -- Failure to Respond to an Office Action2002-07-26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Covington
QuintilesIMS
Daiichi Sankyo
Medtronic
Farmers Insurance
Chubb
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot